Solid tumors in children are biologically distinct from adult cancers. They require specialists who
understand pediatric tumor behavior, dosing, and surgical planning, not adaptations of adult
protocols.
Neuro-Oncology
Brain tumors are the most common solid tumors in children. HCG's multidisciplinary neuro-oncology
team manages the range of pediatric CNS malignancies, with neurosurgical, radiation, and medical
oncology inputs at every case review.
Neuroblastoma, a tumor of the adrenal gland and sympathetic nervous system that predominantly
affects young children, is managed through risk-adapted protocols that account for the wide
variation in disease behavior this tumor shows across age groups.
Retinoblastoma, the most common eye tumor in children, is treated with a strong emphasis on globe
salvage: preserving the eye and maximizing visual function wherever the disease stage allows.
Bone & Soft Tissue
HCG treats osteosarcoma and Ewing's sarcoma, the two most common bone tumors, in children and
adolescents with combined chemotherapy and surgical planning that increasingly prioritizes
limb-sparing approaches.
Rhabdomyosarcoma and other soft tissue sarcomas, hepatoblastoma (liver tumors), and germ cell tumors
complete the range of solid malignancies managed here, each through disease-specific protocols
developed in alignment with international pediatric oncology groups.
High-Precision Care
Every solid tumor case is reviewed by HCG's multidisciplinary tumor board before treatment begins.
Surgical, systemic, and radiation strategies are agreed upon collectively, not determined by a
single specialist working in isolation.
